Individualized functional connectivity markers associated with motor and mood symptoms of Parkinson’s disease

Louisa Dahmani,Yan Bai,Wei Zhang,Jianxun Ren,Shiyi Li,Qingyu Hu,Xiaoxuan Fu,Jianjun Ma,Wei Wei,Meiyun Wang,Hesheng Liu,Danhong Wang
DOI: https://doi.org/10.1101/2024.01.31.578238
2024-02-02
Abstract:Parkinson’s disease (PD) is a complex neurological disorder characterized by many motor and non-motor symptoms. While most studies focus on the motor symptoms of the disease, it is important to identify markers that underlie different facets of the disease. In this case-control study, we sought to discover reliable, individualized functional connectivity markers associated with both motor and mood symptoms of PD. Using functional MRI, we extensively sampled 166 patients with PD (64 women, 102 men; mean age=61.8 years, SD=7.81) and 51 healthy control participants (32 women, 19 men; mean age=55.68 years, SD=7.62). We found that a model consisting of 44 functional connections predicted both motor (UPDRS-III: Pearson =0.21, FDR-adjusted =0.006) and mood symptoms (HAMD: Pearson =0.23, FDR-adjusted =0.006; HAMA: Pearson =0.21, FDR-adjusted =0.006). Two sets of connections contributed differentially to these predictions. Between-network connections, mainly connecting the sensorimotor and visual large-scale functional networks, substantially contributed to the prediction of motor measures, while within-network connections in the insula and sensorimotor network contributed more so to mood prediction. The middle to posterior insula region played a particularly important role in predicting depression and anxiety scores. We successfully replicated and generalized our findings in two independent PD datasets. Taken together, our findings indicate that sensorimotor and visual network markers are indicative of PD brain pathology, and that distinct subsets of markers are associated with motor and mood symptoms of PD.
Neuroscience
What problem does this paper attempt to address?
The paper aims to address the issue of individualized functional connectivity biomarkers related to motor and emotional symptoms in patients with Parkinson's disease (PD). Specifically, the research objectives include: 1. **Discovering reliable functional connectivity biomarkers**: By using functional magnetic resonance imaging (fMRI), the researchers aim to identify a set of functional connectivity biomarkers that are significantly associated with motor and emotional symptoms in Parkinson's disease patients. 2. **Addressing challenges**: To overcome the limitations of previous studies, such as the heterogeneity of symptom presentation, the lack of individualized brain measurement methods, and insufficient quality and quantity of imaging data, this study employed extensive fMRI data collection (approximately 31 minutes and 10 seconds per subject) and individualized approaches to obtain precise functional connectivity measurements. 3. **Validating the reliability and generalizability of the biomarkers**: The study not only identified these biomarkers in the primary cohort but also replicated the findings in two independent datasets to ensure that the discovered biomarkers have good reliability and generalizability. 4. **Associating symptom severity**: The research further explored whether these biomarkers can effectively reflect the severity of motor symptoms (such as Unified Parkinson's Disease Rating Scale Part 3 [UPDRS-III] scores, Hoehn and Yahr scores) and emotional symptoms (such as Hamilton Depression Rating Scale [HAMD] and Hamilton Anxiety Rating Scale [HAMA] scores) in Parkinson's disease patients. In summary, the main goal of this study is to identify and validate a set of functional connectivity biomarkers that can effectively reflect the motor and emotional symptoms of Parkinson's disease patients and to explore the relationship between these biomarkers and symptom severity.